Quantbot Technologies LP Atara Biotherapeutics, Inc. Transaction History

Quantbot Technologies LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$1.5 - $3.04 $5,850 - $11,856	3,900 New	3,900 $6,000
Q2 2022 Aug 09, 2022	BUY	$4.69 - $9.84 $63,980 - $134,237	13,642 New	13,642 $106,000
Q3 2021 Nov 09, 2021	SELL	$11.99 - $17.9 $20,922 - $31,235	-1,745 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$12.89 - $16.58 $280,421 - $360,697	-21,755 Reduced 92.57%	1,745 $27,000
Q1 2021 May 14, 2021	BUY	$14.0 - $20.72 $303,590 - $449,313	21,685 Added 1194.77%	23,500 $337,000
Q4 2020 Feb 12, 2021	SELL	$12.67 - $26.23 $32,650 - $67,594	-2,577 Reduced 58.67%	1,815 $35,000
Q3 2020 Nov 16, 2020	BUY	$11.92 - $15.87 $52,352 - $69,701	4,392 New	4,392 $56,000
Q2 2020 Aug 13, 2020	SELL	$7.53 - $14.93 $534 - $1,060	-71 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$5.69 - $17.78 $403 - $1,262	71 New	71 $0
Q4 2019 Feb 10, 2020	SELL	$10.89 - $16.79 $5,445 - $8,395	-500 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$12.03 - $19.94 $43,308 - $71,784	-3,600 Reduced 87.8%	500 $7,000
Q2 2019 Aug 13, 2019	BUY	$19.05 - $41.04 $78,105 - $168,264	4,100 New	4,100 $82,000
Q2 2018 Aug 13, 2018	SELL	$35.15 - $51.45 $20,527 - $30,046	-584 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$18.0 - $48.35 $10,512 - $28,236	584 New	584 $22,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.